Mednet Logo
HomeQuestion

What treatment regimen would you recommend for a patient with biopsy-proven giant cell arteritis and diffuse cutaneous systemic sclerosis?

2
2 Answers
Mednet Member
Mednet Member
Rheumatology · Mayo Clinic

This is a challenging situation in which you must weigh the well-known high risk of irreversible blindness in untreated GCA with the known increased risk (but not necessarily 100% risk) of scleroderma renal crisis with steroid exposure >=15mg (Steen and Medsger, PMID 9751093). It is important to und...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Rheumatology · Yale School of Medicine

Prednisone 0.5 mg - 1 mg/Kg PO QD (counseling patient to check BP daily and report consistently elevated BP readings 20 points higher diastolic or systolic values: concern for precipitating scleroderma renal crisis) and tocilizumab 162 mg SC weekly (as long as no history of diverticulosis). As you k...

Register or Sign In to see full answer

What treatment regimen would you recommend for a patient with biopsy-proven giant cell arteritis and diffuse cutaneous systemic sclerosis? | Mednet